Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Moncton, Quebec, New York NY, East Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
for
Immune Thrombocytopenia
Location: Danvers MA, Boston MA, The Bronx NY, Albany NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07007962
Phase3, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase3, Recruiting
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model
for
Substance Use, Healthy
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18 - 22
Code: NCT07094061
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Boston MA, Providence RI, New York NY, Myrtle Beach SC,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07181161
Phase1, Phase2, Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Norfolk VA, Chapel Hill NC, Grand Rapids MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase2, Phase3, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New Haven CT, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase1, Recruiting
Long-term Evaluation of a Nasopharyngeal Airway
for
Sleep Apnea, Obstructive
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT07191314
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Boston MA, Providence RI, New Haven CT, The Bronx NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase3, Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Boston MA, Great Neck NY, New York NY, Montreal,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase2, Recruiting
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
for
Participants With Advanced Solid Tumor Malignancies
Location: Fairfax VA, Grand Rapids MI, Houston TX, San Antonio TX,
Sponsor: VelaVigo Bio Inc
Sex: All
Age: 18+
Code: NCT07136779
Phase1, Phase2, Recruiting
Outcomes After Planned Discontinuation of AntiSeizure Medication
for
Epilepsy
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT07750496
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Testing the Impact of the Parenting Young Children Check-up